Can Wegovy (Semaglutide) Cause Erectile Dysfunction?

What the Official Side Effect Data Actually Says

If you have searched the official prescribing information for Wegovy or Ozempic looking for erectile dysfunction in the side effect list, you will not find it. Novo Nordisk's large STEP and SUSTAIN clinical trial programs did not identify ED as a notable adverse event, and it does not appear on the published adverse event tables from those studies.

That said, there is an important caveat. Those trials were not designed to measure sexual function as a primary outcome. Participants were not systematically asked about erection quality or sexual satisfaction. This leaves a real data gap, meaning the absence of ED on the official list reflects what was measured rather than a comprehensive picture of the drug's effects. Post-market surveillance through the FDA Adverse Event Reporting System has included isolated ED complaints, but no causal link has been established at the population level, and those reports are proportionally low given the tens of millions of prescriptions written for semaglutide.

How Semaglutide Interacts With the Systems Behind Erections

Erections depend on a precise coordination of vascular health, testosterone availability, nerve signaling, and psychological state. Obesity and type 2 diabetes are well-known disruptors of all four of these systems, which is why ED is so common in the men most likely to be prescribed semaglutide.

What makes the picture more complex is that GLP-1 receptors are present in penile tissue and in the hypothalamus, a brain region involved in sexual arousal. This means semaglutide may have direct physiological effects on sexual function that researchers have not yet fully characterized. Studies specifically designed to investigate this are still emerging.

One mechanism worth noting is that significant caloric restriction and rapid weight loss can temporarily reduce testosterone levels. Since testosterone plays a role in libido and erectile function, a short-term dip during the early months of treatment is a plausible contributing factor for some men. This effect tends to be transient and may reverse as weight stabilizes.

The Case That Semaglutide May Actually Improve Sexual Health

The stronger argument in the current literature is that semaglutide is more likely to improve erectile function over time than to cause harm. Here is why.

Obesity is one of the most powerful independent risk factors for ED, operating through reduced testosterone, poor endothelial function, and systemic inflammation. Semaglutide produces meaningful, sustained weight loss in most users. By reducing body weight, it also reduces the biological burden that suppresses sexual function.

Improved insulin sensitivity and lower blood glucose levels, two direct pharmacological effects of semaglutide, directly benefit the endothelium, the inner lining of blood vessels that controls blood flow during an erection. Healthier endothelial function is the same mechanism targeted by common ED medications.

A 2024 observational study published in the Journal of Sexual Medicine found that GLP-1 receptor agonist users had lower rates of ED compared to matched controls taking other diabetes medications. Researchers and clinicians are now calling for dedicated randomized controlled trials that measure sexual function as a primary outcome in GLP-1 studies, which would provide much cleaner answers.

Why Some Men Report Worsening ED After Starting the Drug

Even if semaglutide is unlikely to cause ED through its core mechanism, some men do notice changes in sexual function after starting treatment, and those experiences deserve a real explanation.

The most common early side effects of semaglutide include nausea, fatigue, and significant appetite suppression. These are not minor inconveniences. Persistent fatigue and feeling consistently unwell reduce libido and create the conditions for situational ED, a form of ED tied to circumstances rather than a fixed physiological problem. This type of ED tends to resolve as the body adjusts to the medication, typically within the first four to eight weeks.

Psychological factors also matter. Rapid body changes, shifts in relationship dynamics during weight loss, and performance anxiety can all manifest as sexual dysfunction. Men who simultaneously change other medications or overhaul lifestyle habits during this period make it especially difficult to isolate semaglutide as the culprit.

Comparing ED Risk Factors and Semaglutide's Likely Influence

When to Seek a Medical Evaluation

If you notice changes in erectile function after starting semaglutide, the most important step is to talk with a clinician rather than stopping the medication on your own. The conditions semaglutide is prescribed to treat, obesity and type 2 diabetes, are themselves significant ED drivers. Discontinuing the drug without addressing those underlying conditions could make things worse, not better.

A thorough evaluation should include testosterone levels, cardiovascular markers, and a review of any other medications that may interact with sexual function. Timing is a useful clue as well. ED that appears in the first four to eight weeks is more likely tied to the drug's transient side effects or to adjustment-related anxiety. ED that develops or persists after the initial adjustment period warrants a deeper look at hormonal and vascular factors.

Doctronic has completed more than 22 million AI consultations, with a 99.2% treatment plan alignment with board-certified physicians, and offers men a fast, private way to start that conversation any time of day or night. Getting a clear picture of what is actually driving ED is far more useful than guessing, and it puts you in a better position to make informed decisions alongside your care team.

Frequently Asked Questions

Does Wegovy cause erectile dysfunction as an official side effect?

No. Erectile dysfunction does not appear on Novo Nordisk's official adverse event lists from the large STEP or SUSTAIN clinical trials. However, those trials were not designed to track sexual function as a primary outcome, so there is a recognized data gap. Absence of evidence in this case is not the same as evidence of absence.

Can losing weight on semaglutide actually improve erectile dysfunction?

Possibly, yes. Obesity is one of the strongest independent risk factors for ED. Meaningful weight loss improves endothelial function, lowers blood glucose, and reduces cardiovascular strain, all mechanisms directly tied to erection quality. Small observational studies and patient reports suggest ED improvement is more common than worsening among men who achieve significant weight loss on GLP-1 therapy.

Why did my ED get worse after starting Ozempic?

Several indirect factors may be at play. Nausea, fatigue, and appetite suppression common in the early weeks of GLP-1 therapy can reduce libido and cause situational ED. Psychological stress around rapid body changes or relationship dynamics can also contribute. If ED began in the first four to eight weeks, it is more likely tied to these temporary side effects than to the drug's core mechanism.

Does semaglutide lower testosterone in men?

There is some evidence that significant caloric restriction and rapid weight loss, both triggered by semaglutide, can temporarily lower testosterone levels. Low testosterone is a known contributor to ED. However, longer-term weight loss has generally been associated with testosterone improvement in men with obesity, so this effect may be transient rather than persistent.

Should I stop taking semaglutide if I develop erectile dysfunction?

Do not stop semaglutide on your own without speaking to a clinician first. The conditions it treats, including obesity and type 2 diabetes, are themselves major drivers of ED. A physician can check testosterone, cardiovascular markers, and medication interactions to find the actual cause before making any changes to your treatment plan.

The Bottom Line

The current clinical evidence does not support semaglutide as a direct cause of erectile dysfunction. In fact, the balance of emerging data suggests that GLP-1 therapy may improve erectile function over time for many men by addressing obesity, insulin resistance, and cardiovascular risk. Temporary ED in the early weeks is more likely linked to fatigue, nausea, or anxiety than to the drug itself. If you are concerned about sexual health changes while taking Wegovy or Ozempic, a personalized medical evaluation is the right next step. Doctronic, the first AI legally authorized to practice medicine, offers free AI consultations and $39 video visits available 24/7, so you can get a thorough assessment without a long wait. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.